Physician

Jeremy Jacob Prine, M.D.

According to 2025 Medicare claims, Jeremy Prine, M.D. (NPI: 1508000332) practices pain management in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is NEXUS PAIN CENTER OF HOUSTON COUNTY (NPI: 1871681957; TIN: 20-4184138) and primary practice location at 31088-8965. Prine is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Prine's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 556 traditional Medicare patients, billed 7,058 HCPCS/CPT codes, and received $457,107 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,608 prescription claims across 567 beneficiaries totaling $146,527 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 20 records totaling $954. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $249,999 to $146,527. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,166	9,553	$422,243
2016	1,144	5,280	$377,068
2017	1,032	7,482	$403,178
2018	1,281	8,656	$433,949
2019	1,353	8,166	$431,015
2020	1,080	7,221	$412,437
2021	753	6,695	$426,816
2022	606	6,080	$412,183
2023	609	6,986	$480,614
2024	556	7,058	$457,107

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	947	4,736	$249,999
2016	945	5,314	$289,491
2017	862	4,392	$216,126
2018	1,067	4,831	$250,982
2019	1,053	4,087	$181,015
2020	962	4,248	$148,120
2021	716	4,254	$132,472
2022	660	4,966	$150,121
2023	569	5,496	$171,935
2024	567	5,608	$146,527

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	196	446	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	420	1,439	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	422	1,278	$64
80307	Testing for presence of drug, by chemistry analyzers	207	582	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	165	873	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,924	56,906	$48,342
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	531	15,609	$14,933
Movantik	Naloxegol Oxalate	35	1,080	$14,003
Pregabalin	Pregabalin	475	17,013	$12,276
Lidocaine	Lidocaine	85	2,723	$8,885

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$954	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeremy Jacob Prine, M.D.?

Tedicare shows public-source Medicare data for Jeremy Jacob Prine, M.D. (NPI 1508000332), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeremy Jacob Prine, M.D. have ACO affiliation data?

Jeremy Jacob Prine, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Jeremy Jacob Prine, M.D.?

Jeremy Jacob Prine, M.D. is linked to NEXUS PAIN CENTER OF HOUSTON COUNTY (billing NPI 1871681957) in the available physician profile data.

Does Jeremy Jacob Prine, M.D. have Open Payments data?

Jeremy Jacob Prine, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.